A possible Apollo collaboration
A future collaboration could connect Programmable Bio's operational autonomous lab with consented, ethics-approved clinical research programs. Any such work would require a negotiated agreement defining scope, lawful purpose, consent, data roles, security, publication, IP, economics, and oversight.
Principles for a responsible proposal
Purpose-limited access
Every dataset or biospecimen cohort tied to an approved research question, consent scope, and retention period.
Data minimization
Prefer controlled, federated, or de-identified analysis. Do not move raw clinical data simply because it is technically possible.
Independent oversight
Institutional ethics review, scientific governance, audit trails, and documented responsibility for each party.
No implied exclusivity
Exclusivity, commercial rights, and branding would exist only if expressly agreed in signed documents.
Illustrative collaboration structure
| Workstream | Possible Apollo role | Possible Programmable Bio role |
|---|---|---|
| Pilot validation cohort | Ethics-approved sample and phenotype governance | Automated assay execution and structured experimental data |
| Biomarker study | Clinical question, cohort definition, investigator oversight | Assay design, reproducible execution, analytical tooling |
| Federated analysis | Approved compute and access controls | Containerized analysis and provenance records |
| Joint translation | Clinical interpretation and study pathway | Experimental iteration and model-ready evidence |
Milestones before any public partnership claim
- Named executive and scientific sponsors on both sides
- Signed MoU or definitive research agreement
- Defined pilot, ethics path, consent basis, and data-governance design
- Approved public wording and trademark use
- Measured pilot outcomes before commercial claims
Fallback path
The autonomous-lab business does not depend on Apollo. The Hyderabad lab can scale standardized validation independently. If an Apollo agreement is not reached, clinical-context programs can be pursued later with other hospitals, biobanks, or research institutions under equivalent governance.